发明名称 |
Bile acid or bile salt fatty acid conjugates |
摘要 |
A method for treating a disease or disorder associated with altered glucose metabolism or insulin action in a subject in need thereof. The method includes administering to the subject a BAFAC (bile acid or bile salt fatty acid conjugate) of general formula II:
W-X-G
in which G is a bile acid or bile salt radical, which is optionally conjugated in position 24 with a suitable amino acid, W stands for one or two fatty acid radicals, each having from 14-22 carbon atoms, and X is a suitable bonding member or a direct C═C bond between G and each W, said suitable bonding member being selected from the group consisting of NH, O, P and S. The disease or disorder associated with altered glucose metabolism is selected from the group consisting of hyperglycemia, diabetes, insulin resistance and obesity. |
申请公布号 |
US8975246(B2) |
申请公布日期 |
2015.03.10 |
申请号 |
US201213366796 |
申请日期 |
2012.02.06 |
申请人 |
Galmed Research and Development Ltd. |
发明人 |
Gilat Tuvia |
分类号 |
A61K31/575;A61K47/48;C07J9/00;C07J41/00 |
主分类号 |
A61K31/575 |
代理机构 |
Winston & Strawn LLP |
代理人 |
Winston & Strawn LLP |
主权项 |
1. A method for treating a disease or disorder associated with altered glucose metabolism or insulin action in a subject in need thereof, said method comprising the step of administering to the subject a BAFAC (bile acid or bile salt fatty acid conjugate) of general formula II
W-X-G in which G is a bile acid or bile salt radical, which is optionally conjugated in position 24 with a suitable amino acid, W stands for one or two fatty acid radicals, each having from 14-22 carbon atoms, and X is a suitable bonding member or a direct C═C bond between G and each W, said suitable bonding member being selected from the group consisting of NH, O, P and S, wherein the disease or disorder associated with altered glucose metabolism is selected from the group consisting of hyperglycemia, diabetes. |
地址 |
Tel-Aviv IE |